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Purpose
Despite the benefits of minimally invasive surgery for cervical cancer, there are a lack of
randomized trials comparing laparoscopic radical hysterectomy and abdominal radical hys-
terectomy. We compared morbidity, cost of care, and survival between abdominal radical
hysterectomy and laparoscopic radical hysterectomy for cervical cancer.
Materials and Methods
We used the Korean nationwide database to identify women with cervical cancer who 
underwent radical hysterectomy from January 1, 2011 to December 31, 2014. Patients
who underwent abdominal radical hysterectomy were compared to those who underwent
laparoscopic radical hysterectomy. Perioperative morbidity, the use of adjuvant therapy,
and survival were evaluated after propensity score balancing. 
Results
We identified 6,335 patients, including 3,235 who underwent abdominal radical hysterec-
tomy and 3,100 who underwent laparoscopic radical hysterectomy. The use of laparoscopic
radical hysterectomy increased from 46.1% in 2011 to 51.8% in 2014. Patients who were
younger, had a more recent year of diagnosis, and were treated in the metropolitan area
were more likely to undergo a laparoscopic procedure (p < 0.001). Compared to abdominal
radical hysterectomy, laparoscopic radical hysterectomy was associated with lower rates of
complication, fewer transfusions, a shorter hospital stay, less adjuvant therapy, and reduced
total medical costs (p < 0.001). Laparoscopic surgery was associated with a better overall
survival than abdominal operation (hazard ratio, 0.74; 95% confidence interval, 0.64 to
0.85).       
Conclusion
In the postdissemination era, laparoscopic radical hysterectomy was associated with more
favorable morbidity profiles, a lower cost of care, and comparable survival than abdominal
radical hysterectomy.
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Introduction
Originally described by Wertheim in the 1890s and subse-
quently re-popularized by Meigs in the 1950s, radical hys-
terectomy has long been established as a standard treatment
for early-stage cervical cancer [1]. Although abdominal rad-
ical hysterectomy represented the standard surgical approa-
ch for many years, minimally invasive approaches have been
widely adopted in gynecologic oncology over the past few
decades [2,3].
Radical hysterectomy and pelvic lymphadenectomy are
standard surgical treatments for early-stage cervical cancer.
Despite the excellent 5-year overall survival rate [4,5], the
surgical treatment resulted in substantial long-term morbid-
ity, such as lower urinary track dysfunction, sexual dysfunc-
tion, and colorectal motility disorders [6-8]. Furthermore, the
surgical approach was traditionally performed through lapa-
rotomy and associated with a high incidence of perioperative
morbidity and mortality.
Laparoscopic radical hysterectomy was introduced to 
decrease the morbidity of the operative procedure. Numer-
ous retrospective studies have compared laparoscopic and
abdominal radical hysterectomy for cervical cancer, and
showed that the laparoscopic approach is oncologically safe
and associated with fewer postoperative complications and
earlier recovery [9-16]. However, there have been concerns
about the oncologic safety of laparoscopic radical hysterec-
tomy due to difficulties in achieving a sufficient resection
margin from the complex procedure itself. However, patient
acceptance of minimally invasive surgery increases even in
the absence of randomized phase III trials that show advan-
tages to these procedures [17]. Currently, only one random-
ized clinical trial is evaluating laparoscopic or robotic radical
hysterectomy with abdominal radical hysterectomy in pati-
ents with early-stage cervical cancer [18]. 
Despite the common use of minimally invasive surgery 
operation for cervical cancer, there are no population-level
data evaluating survival after the procedure in unselected
patients. We performed a population-based analysis to com-
pare the effectiveness between abdominal radical hysterec-
tomy and laparoscopic radical hysterectomy for cervical
cancer.
Materials and Methods
1. Data source
The Korean Health Insurance Review and Assessment
Service (HIRA) database was used for the analysis. HIRA is
an independent body established to review the claims data
and assess the quality of health care. In Korea, since health
insurance is applied to all citizens and it is a fee-for-service
system, everyone’s health information is coded and regis-
tered in the HIRA database. Therefore, this database captures
inpatient and outpatient data on disease and services (pro-
cedures and operations) in a timely manner. Disease codes
used in the HIRA database are standardized according to the
Korean Classification of Disease, sixth version, which follows
the International Classification of Diseases, 10th edition
(ICD-10) [19]. Procedure and operation codes use HIRA’s
own code and are released yearly [20].  
2. Cohort selection
Women 18 years and older who underwent radical hys-
terectomy for cervical cancer were identified from the HIRA
database between January 1, 2011 and December 31, 2014. A
multidisciplinary panel consisting of gynecologic oncologists
(J.Y.L., K.K., M.C.L., and J.W.K.) and epidemiologists (J.H.K.,
K.K., and S.J.P.) identified the patients with newly diagnosed
cervical cancer. Disagreements were resolved by consensus
after discussion. Newly diagnosed cervical cancer in a pati-
ent with radical hysterectomy was defined by using the fol-
lowing criteria: the presence of an ICD-10 code for cervical
cancer and HIRA operation codes for radical hysterectomy.
ICD-10 codes for cervical cancer were C530, C531, C538, and
C539. HIRA operation codes for radical hysterectomy were
R4154 and R4155.
Patients were stratified into two groups based on the type
of radical hysterectomy performed: abdominal or laparo-
scopic. To identify women who underwent the laparoscopic
procedure, the database was searched to identify charges for
laparoscopic materials (N0031001). In Korea, insurance does
not cover the cost of robotic operation. Therefore, robotic 
operation could not be identified in this database.
3. Characteristics
Patient characteristics analyzed included age at operation,
year of diagnosis, insurance status (Medicare or Medicaid),
comorbidities (Charlson comorbidity index [21] score), and
the extent of lymphadenectomy. Hospital characteristics 
analyzed included the hospital location (metropolitan or
nonmetropolitan), hospital region (metropolitan area [Seoul/
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Gyeonggi Province], Middle [Chungcheong Province], East
[Gangwon Province], South West [Jeolla Province], and
South East [Gyeongsang Province]), and hospital size (ter-
tiary general hospital, general hospital, hospital, or clinic).
4. Outcomes
The primary outcome was overall survival. Death was
deemed to have occurred when patients did not use any
medical service for 12 consecutive months after discharge.
Additionally, perioperative morbidity and mortality were
analyzed. Perioperative mortality was defined as in-hospital
death. Perioperative morbidity and the use of blood transfu-
sions were recorded. We used methods in previous studies
in obtaining morbidity and survival data extraction from
HIRA database [22,23]. To identify complications, diagnostic
and procedure codes were used (S1 Table). Perioperative
morbidity was classified into the following categories: (1) 
intraoperative complications (bladder injury, ureter injury,
intestinal injury, and vascular injury); (2) postoperative com-
plications (bladder dysfunction, lymphocele, lymphedema,
bowel obstruction, and fistula); (3) surgical site complications
(wound abscess, disruption, and incisional hernia); (4) med-
ical complications (venous thromboembolism, myocardial
infarction, cardiopulmonary arrest, respiratory failure, renal
failure, bacteremia/sepsis, shock, pneumonia, delirium, acute
pyelonephritis, and stroke). Blood transfusions during hos-
pitalization for the operation were counted. For intraopera-
tive complications among perioperative morbidities, the
event that occurred during hospitalization for the operation
was considered, whereas for postoperative complications,
surgical site complications, medical complication, and events
that occurred within 6 months postoperatively were consid-
ered. The aforementioned complications were assessed using
the 6th revision of the Korean Standard Classification of Dis-
eases based on ICD-10 and current procedural terminology
codes (S1 Table).
The use of adjuvant vaginal brachytherapy, whole pelvic
radiation, and chemotherapy during the 3 months postoper-
atively was noted for each patient.
The HIRA database includes an itemized, data-stamped
log of all items billed to a patient, including drugs, laboratory
and radiologic tests, and therapeutic services. Medical costs
per person during hospitalization for the operation within
30 days, 90 days, and 6 months postoperatively were evalu-
ated. This analysis did not consider uninsured benefits. All
costs were reported in December 31, 2014 in United States
(US) dollars with an exchange rate of 1 US dollar equaling
1,107 Korean won. Costs are reported as medians and inter-
quartile ranges. This study also analyzed use of the intensive
care unit service, 30-day reoperation, non-routine discharge,
30-day readmission, 30-day emergency room visit, and leng-
th of stay for the operation by capitalizing on the HIRA data-
base.
5. Statistical analysis
Frequency distributions between categorical variables were
compared using the chi-square test, and continuous variables
were compared with the Student t test. The multivariable 
logistic regression that included patients and hospital char-
acteristics was used to identify the factors that affect the use
of laparoscopic radical hysterectomy.
The inverse probability of treatment weighting (IPTW)
method based on the propensity score was applied to balance
the observed confounders between the methods of operation.
With this technique, weights for patients who underwent 
laparoscopic radical hysterectomy were the inverse of 
1-propensity score, and weights for patients who had abdo-
minal radical hysterectomy were the inverse of the propen-
sity score [24]. The propensity score was the predicted pro-
bability of treatment, laparoscopic radical hysterectomy, or
abdominal radical hysterectomy, in this analysis [25,26]. To
calculate the propensity score, we used a logistic regression
model that included patient characteristics (age at operation,
year of diagnosis, insurance status, comorbidities, and the
extent of lymphadenectomy), hospital characteristics (hospi-
tal location, hospital region, and hospital size), and two-way
interaction terms. The predicted probability was estimated
for each patient. After propensity score balancing, subse-
quent treatment, morbidity, and mortality were compared
between the two groups. Overall mortality was evaluated 
between the two groups using the Kaplan-Meier method and
Cox proportional hazard models. All statistical tests were
two-sided. A p-value of < 0.05 was considered statistically
significant. To perform all statistical analyses, SAS software
ver. 9.1.3 (SAS Institute Inc., Cary, NC) was used.
6. Ethical statement
This study was approved by the institutional review board
of Yonsei University Health System, Severance Hospital 
(approval No. 4-2016-0440). As HIRA database are publicly
available, written informed consent was waived for this
study.
Results
We identified 6,335 patients, including 3,235 women
(51.1%) who underwent abdominal radical hysterectomy and
3,100 (48.9%) who underwent laparoscopic radical hysterec-
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tomy. The use of laparoscopic surgery increased with time.
The use of laparoscopic radical hysterectomy increased from
46.1% in 2011 to 51.8% in 2014 (p for trend=0.016) (Fig. 1).
Table 1 shows the characteristics of women who underwent
abdominal radical hysterectomy versus laparoscopic radical
hysterectomy. When patients were stratified according to the
surgical approach, statistically significant differences were
observed with respect to age, year of diagnosis, insurance
status, comorbidities, the extent of lymphadenectomy, and
hospital region. After propensity score balancing, there was
no significant difference in these variables between the two
groups.
In a multivariable model for identifying predictors of 
undergoing laparoscopic operation, age was the strongest
predictor associated with minimally invasive operation. 
Patients who were younger, had a more recent year of diag-
nosis, were hospitalized in a metropolitan area, and had a
Medicare insurance status were more likely to undergo lapa-
roscopic radical hysterectomy (p < 0.05 for all) (S2 Table). In
contrast, patients with more medical comorbidities who were
hospitalized at a small-sized hospital (a hospital or clinic)
were less likely to undergo a laparoscopic radical hysterec-
tomy (p < 0.05 for all) (S2 Table).
Laparoscopic radical hysterectomy had favorable morbid-
ity profiles and a health care utilization index compared to
abdominal radical hysterectomy (S3 Table). Compared with
abdominal radical hysterectomy, laparoscopic radical hys-
terectomy was associated with fewer intraoperative compli-
cations (9.9% vs. 12.0%, p < 0.001), fewer postoperative
complications (19.5% vs. 21.7%, p=0.002), and fewer surgical
site complications (6.2% vs. 8.1%, p < 0.001). Regarding the
health utilization index, the median length of stay was
shorter with laparoscopic radical hysterectomy than with 
abdominal radical hysterectomy (p < 0.001). When focusing
on inpatient outcomes, the median cost of care was higher
with laparoscopic radical hysterectomy than with abdominal
hysterectomy (US $4,421 vs. $4,147), although this difference
was not statistically significant. When focusing on postoper-
ative outcomes, patients undergoing laparoscopic radical
hysterectomy had lower 30-day reoperation rates. In addi-
tion, patients undergoing laparoscopic radical hysterectomy
were associated with a lower cost of care within 30 days, 90
days, and 6 months after discharge.
The overall rates of intraoperative complications (odds
ratio [OR], 0.73; 95% confidence interval [CI], 0.63 to 0.86),
surgical site complications (OR, 0.73; 95% CI, 0.60 to 0.88),
medical complications (OR, 0.88; 95% CI, 0.79 to 0.98), and
blood transfusions (OR, 0.28; 95% CI, 0.25 to 0.31) were lower
with laparoscopic radical hysterectomy than with abdominal
radical hysterectomy (Table 2). After propensity score bal-
ancing, laparoscopic radical hysterectomy still had lower
rates of intraoperative complications (OR, 0.80; 95% CI, 0.72
to 0.90), postoperative complications (OR, 0.87; 95% CI, 0.80
to 0.95), surgical site complications (OR, 0.75; 95% CI, 0.66 to
0.86), and blood transfusions (OR, 0.30; 95% CI, 0.28 to 0.33).
In addition, the rate of use of adjuvant therapy was lower
(OR, 0.63; 95% CI, 0.57 to 0.69) in patients who underwent
laparoscopic radical hysterectomy than in those who under-
went abdominal radical hysterectomy.
Table 3 demonstrates the cumulative hazards of adverse
outcomes in patients in receiving either laparoscopic or 
abdominal radical hysterectomy using unadjusted and adju-
sted multivariable analyses. Unadjusted Cox regression
models showed that laparoscopic radical hysterectomy was
associated with better overall survival (hazard ratio [HR],
0.52; 95% CI, 0.43 to 0.63). Additionally, laparoscopic radical
hysterectomy was associated with better overall survival
when adjusting for IPTW or IPTW and the covariates. When
we performed sensitivity analysis for patients who under-
went adjuvant therapy and no adjuvant therapy, the laparo-
scopic radical hysterectomy group had better survival than
the abdominal radical hysterectomy group. This finding was
pronounced in patients with no adjuvant therapy (HR, 0.52;
95% CI, 0.41 to 0.66) and the benefits of laparoscopy were
marginal in patients with adjuvant therapy (HR, 0.85; 95%
CI, 0.72 to 0.99). Likewise, survival statistically significantly
improved among patients undergoing laparoscopic radical
hysterectomy in all Kaplan-Meier analyses (Fig. 2).
Fig. 1.  Trends in the use of laparoscopic and abdominal
radical hysterectomy (2011-2014).
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Discussion
During the study period, approximately half of all radical
hysterectomies performed in Korea were done laparoscopi-
cally. Using a cohort of patients treated in the postdissemi-
nation era, we showed that laparoscopic radical hysterec-
tomy was associated with lower rates of complications, lower
cost of care, and better survival outcomes than abdominal
radical hysterectomy.
Despite limited evaluation of the comparative effectiveness
between laparoscopic radical hysterectomy and abdominal
Characteristic Total
Unadjusted Inverse probability of treatment weightinga)
Abdominal RH Laparoscopic RH p-valueb) Abdominal RH Laparoscopic RH p-valuec)
Total patients 6,335 (100) 3,235 (100) 3,100 (100) 3,171 (100) 3,166 (100)
Age at operation (yr)
 39 1,265 (20.0) 587 (18.1) 678 (21.9) < 0.001 617 (19.5) 634 (20.0) 0.785
40-49 2,066 (32.6) 1,044 (32.3) 1,022 (33.0) 1,045 (33.0) 1,020 (32.2)
50-59 1,732 (27.3) 898 (27.8) 834 (26.9) 869 (27.4) 874 (27.6)
 60 1,272 (20.1) 706 (21.8) 566 (18.3) 640 (20.2) 638 (20.2)
Year of diagnosis
2011 1,617 (25.5) 872 (27.0) 745 (24.0) 0.016 813 (25.6) 807 (25.5) 0.647
2012 1,572 (24.8) 806 (24.9) 766 (24.7) 777 (24.5) 800 (25.3)
2013 1,648 (26.0) 835 (25.8) 813 (26.2) 836 (26.4) 809 (25.6)
2014 1,498 (23.6) 722 (22.3) 776 (25.0) 745 (23.5) 750 (23.7)
Insurance status
Medicare 6,084 (96.0) 3,071 (94.9) 3,013 (97.2) < 0.001 3,044 (96.0) 3,041 (96.1) 0.910
Medicaid 251 (4.0) 164 (5.1) 87 (2.8) 127 (4.0) 125 (3.9)
Comorbidities 
(CCI score)
2 1,874 (29.6) 922 (28.5) 952 (30.7) < 0.001 941 (29.7) 934 (29.5) 0.988
3 1,502 (23.7) 703 (21.7) 799 (25.8) 749 (23.6) 744 (23.5)
4 775 (12.2) 364 (11.3) 411 (13.3) 390 (12.3) 388 (12.3)
 5 2,184 (34.5) 1,246 (38.5) 938 (30.3) 1,091 (34.4) 1,100 (34.7)
Para-aortic 
lymphadenectomy
Yes 2,410 (38.0) 1,354 (41.9) 1,056 (34.1) < 0.001 1,198 (37.8) 1,191 (37.6) 0.827
No 3,925 (62.0) 1,881 (58.1) 2,044 (65.9) 1,973 (62.2) 1,975 (62.4)
Hospital location
Metropolitan 4,635 (73.2) 2,365 (73.1) 2,270 (73.2) 0.915 2,304 (72.7) 2,294 (72.5) 0.803
Nonmetropolitan 1,700 (26.8) 870 (26.9) 830 (26.8) 867 (27.3) 872 (27.5)
Hospital region
Metropolitan area 4,216 (66.6) 1,963 (60.7) 2,253 (72.7) < 0.001 2,114 (66.7) 2,109 (66.6) 0.869
Middle 259 (4.1) 136 (4.2) 123 (4.0) 131 (4.1) 133 (4.2)
East 57 (0.9) 47 (1.5) 10 (0.3) 28 (0.9) 34 (1.1)
South West 379 (6.0) 226 (7.0) 153 (4.9) 191 (6.0) 193 (6.1)
South East 1,424 (22.5) 863 (26.7) 561 (18.1) 707 (22.3) 697 (22.0)
Hospital volume
Tertiary general 4,220 (66.6) 2,164 (66.9) 2,056 (66.3) 0.061 2,080 (65.6) 2,070 (65.4) 0.935
hospital
General hospital 2,097 (33.1) 1,057 (32.7) 1,040 (33.5) 1,082 (34.1) 1,086 (34.3)
Hospital and clinic 18 (0.3) 14 (0.4) 4 (0.1) 9 (0.3) 10 (0.3)
Table 1. Characteristics of the cohort that underwent laparoscopic and abdominal radical hysterectomy
RH, radical hysterectomy; CCI, Charlson comorbidity index. a)Frequency numbers were rounded to integers based on weight,
b)The p-values were derived from the chi-square test, c)The p-values were derived from weighted survey logistic model.
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radical hysterectomy, as well as the absence of randomized
trials comparing the two techniques, minimally invasive sur-
gery has been widely used for cervical cancer in the last
decade in Korea. In 2011, 46.1% of radical hysterectomies for
cervical cancer were performed minimally invasively. The
rate of use of minimally invasive surgery in our study was
higher than that in previous studies. Wright et al. [17] repor-
ted that only 15% of patients with cervical cancer underwent
laparoscopic or robotic radical hysterectomy during 2006-
2010 from a population-based database. The widespread use
of laparoscopy in Korea has been attributed to patients’ pref-
erence to minimally invasive operation, acceptance of new
techniques from gynecologic oncologists, and increasing hos-
pital competition due to patients’ demands.
Several of our findings are noteworthy. First, discrepancies
were found in the use of laparoscopic surgery in Korea. Not
only age, year of diagnosis, and comorbidities but modifiable
factors such as one’s insurance status and the hospital region
affects the use of laparoscopic radical hysterectomy. This
finding was in line with that of other studies on hysterec-
tomy for benign and oncologic indications, which showed
Unadjusted
p-value
Adjusted by IPTW
p-value
OR (95% CI) OR (95% CI)
Intraoperative complications 0.73 (0.63-0.86) < 0.001 0.80 (0.72-0.90) 0.008
Postoperative complications 0.97 (0.87-1.07) 0.525 0.87 (0.80-0.95) 0.002
Surgical site complications 0.73 (0.60-0.88) 0.001 0.75 (0.66-0.86) < 0.001
Medical complications 0.88 (0.79-0.98) 0.018 0.99 (0.90-1.08) 0.739
Blood transfusions 0.28 (0.25-0.31) < 0.001 0.30 (0.28-0.33) < 0.001
Postoperative adjuvant therapy 0.59 (0.52-0.67) < 0.001 0.63 (0.57-0.69) < 0.001
Radiation only 0.92 (0.76-1.11) 0.387 0.87 (0.76-0.99) 0.042
Chemotherapy only 0.48 (0.41-0.56) < 0.001 0.55 (0.49-0.61) < 0.001
CCRT 0.44 (0.39-0.49) < 0.001 0.47 (0.43-0.51) < 0.001
Table 2. Comparison of morbidity between patients who underwent laparoscopic and abdominal radical hysterectomy for
cervical cancer
IPTW, inverse probability of treatment weighting; OR, odds ratio; CI, confidence interval; CCRT, concurrent chemoradia-
tion.
All-cause mortality
Unadjusted Adjusted by IPTW Adjusted by IPTW and PoAT                                                  
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
Total 0.52 (0.43-0.63) < 0.001 0.61 (0.53-0.70) < 0.001 0.74 (0.64-0.85) < 0.001
With adjuvant therapy 0.71 (0.56-0.90) 0.005 0.85 (0.72-0.99) 0.046 - -
Without adjuvant therapy 0.48 (0.34-0.67) < 0.001 0.52 (0.41-0.66) < 0.001 - -
Table 3. Hazard ratios for clinical outcomes with laparoscopic versus abdominal radical hysterectomy
IPTW, inverse probability of treatment weighting; PoAT, postoperative adjuvant therapy; HR, hazard ratio; CI, confidence
interval.
Fig. 2.  Overall survival with laparoscopic versus abdom-
inal radical hysterectomy.
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significant disparities in the use of minimally invasive sur-
gery [26].
Second, patients who underwent laparoscopic radical hys-
terectomy had a lower risk of intraoperative complications,
postoperative complications, and surgical site complications
even after propensity matching. An important benefit of min-
imally invasive surgery is lower rates of perioperative mor-
bidity. Numerous prior retrospective studies comparing
laparoscopic radical hysterectomy and laparotomy for cervi-
cal cancer have consistently shown lower complication rates
[9-17]. Most of the studies were based on contemporaneous
series of patients from a single institution. Using population-
based database, Wright et al. [17] showed that minimally 
invasive radical hysterectomy had favorable morbidity pro-
files with a lower rate of complications than abdominal rad-
ical hysterectomy. In this study, only 284 of 1,894 patients
(15%) underwent minimally invasive surgery between 2006
and 2010. In our study, differences in perioperative outcomes 
became more noticeable with 48.9% of patients who under-
went laparoscopic radical hysterectomy, indicating wide use
of minimally invasive surgery.
Third, laparoscopic radical hysterectomy was associated
with a lower total cost of care within 6 months postopera-
tively than open radical hysterectomy. While decision analy-
ses for radical hysterectomy are lacking, a modeling study of
simple hysterectomy for endometrial cancer noted that the
laparoscopic approach was the least expensive approach
from a societal perspective followed by robotic and then 
abdominal hysterectomy [27]. These findings might result
from favorable operative outcomes, such as lower complica-
tion rates, a shorter hospital stay, and fewer blood transfu-
sions, of laparoscopic surgery. In addition, one possible
explanation for these observations may reside in the charac-
teristics of the population evaluated. The age at operation,
comorbidities, and Medicare insurance status represent 
independent predictors of complications and use of the
health care expenditure. Differences in patients’ characteris-
tics might affect these results.
Lastly, we found favorable outcomes in survival for lapa-
roscopic radical hysterectomy compared to abdominal radi-
cal hysterectomy. Previous retrospective studies have shown
non-inferior survival associated with laparoscopic operation
compared with laparotomy [9,10,12,15]. However, these 
results were derived from experienced surgeons with a lim-
ited number of patients. In the Laparoscopic Approach to
Cervical Cancer trial, 740 patients with cervical cancer and
tumors less than 4 cm were randomly assigned to either min-
imally invasive surgery or laparotomy. Although this study
started in January 2008, it is still recruiting participants. The
slow recruitment for this study might be due to rarity of the
tumor in western countries and patients’ reluctance to par-
ticipate in a study if they prefer minimally invasive opera-
tion. Therefore, large observational studies are needed to
evaluate survival outcomes.
Encouragingly, we found better survival outcomes with
laparoscopic radical hysterectomy than with abdominal rad-
ical hysterectomy, before propensity matching. As laparo-
scopic radical hysterectomy was associated with a lower risk
of complications, this benefit may translate to a decrease in
all-cause mortality. The incidence of serious complications,
such as bowel obstruction, cardiopulmonary arrest, renal
failure, and sepsis, was significantly lower with laparoscopic
radical hysterectomy than with abdominal radical hysterec-
tomy. This should be emphasized in clinical practice. How-
ever, selection bias in the choice of surgical procedure might
affect the results. As adjuvant therapy is usually performed
based on pathologic findings after radical hysterectomy, we
found that adjuvant therapy, radiation and chemotherapy in
women who underwent laparoscopic radical hysterectomy,
was used less frequently. This suggests that surgeons tend
to choose laparoscopic radical hysterectomy for small-vol-
ume tumors and select abdominal radical hysterectomy for
large-volume tumors. Therefore, we tried to balance the two
groups with propensity matching and adjusting adjuvant
therapy, and we found the same results of better survival
with laparoscopic radical hysterectomy than with abdominal
radical hysterectomy. In addition, when we performed sen-
sitivity analysis in patients who underwent adjuvant therapy
and no adjuvant therapy, laparoscopic radical hysterectomy
was associated with better survival.
Although we included a large cohort of patients, we rec-
ognize several limitations. First, we lacked data on tumor
characteristics such as the tumor size, stage, histology, and
margin status. Differences in tumor characteristics may not
only have led to selection bias in the choice of procedure, but
also may have influenced procedure-associated morbidity.
Although we tried to balance confounders between treat-
ments with propensity score matching, differences in adju-
vant treatment still exists. Therefore, we did subgroup
analysis according to adjuvant treatment. Second, as with
any study of administrative data, we cannot capture individ-
ual patient and physician preferences that undoubtedly 
influenced the treatment decision-making. Third, claims data
undercapture complications. Therefore, we categorized com-
plications and tried to find events, using diagnostic codes
and procedure codes. Lastly, the HIRA database was not 
intended to identify survival outcomes, so we could not 
obtain recurrence-free survival and determine death indi-
rectly by relying on disqualification of the insurance status.
Two studies presented at the March 2018 Society of Gyne-
cologic Oncology Annual Meeting on Women’s Cancer,
women with early cervical cancer treated by minimally inva-
sive radical hysterectomy were shown to have a significantly
higher risk of disease recurrence and poorer long-term sur-
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vival than those of women treated by open surgery [28,29].
Our results were opposite those mentioned above. Some crit-
icisms were raised for the results of Laparoscopic Approach
to Carcinoma of the Cervix (LACC) trial [30-32], we should
wait for final results coming at least next 2 years. As clini-
cians confused to abandon laparoscopic surgery for early-
stage cervical cancer, our results might be discussed with
patients scheduled to undergo radical hysterectomy in Korea.
In summary, laparoscopic radical hysterectomy was asso-
ciated with a lower risk of perioperative complications and
has comparable outcomes with abdominal radical hysterec-
tomy. However, the use of laparoscopic radical hysterectomy
for cervical cancer has slowly increased since 2011 and now
accounts for more than 50% of operations for this disease. 
Increasing the use of laparoscopic surgery in clinical practice
may be an important and underused strategy to improve cer-
vical cancer outcomes. 
Electronic Supplementary Material
Supplementary materials are available at Cancer Research and
Treatment website (https://www.e-crt.org).
Conflicts of Interest
Conflict of interest relevant to this article was not reported.
Acknowledgments
This study was supported by Bumsuk Academic Research Fund
in 2016.
1. Dursun P, Gultekin M, Ayhan A. The history of radical hys-
terectomy. J Low Genit Tract Dis. 2011;15:235-45.
2. Conrad LB, Ramirez PT, Burke W, Naumann RW, Ring KL,
Munsell MF, et al. Role of minimally invasive surgery in 
gynecologic oncology: an updated survey of members of the
Society of Gynecologic Oncology. Int J Gynecol Cancer. 2015;
25:1121-7.
3. Lee JY, Kim K, Lee TS, Kang S, Seong SJ, Kim JW, et al. Con-
troversies in the management of endometrial cancer: a survey
of the Korean Gynecologic Oncology Group. J Gynecol Oncol.
2015;26:277-83.
4. Jung KW, Won YJ, Kong HJ, Oh CM, Shin A, Lee JS. Survival
of korean adult cancer patients by stage at diagnosis, 2006-
2010: national cancer registry study. Cancer Res Treat. 2013;45:
162-71.
5. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA
Cancer J Clin. 2012;62:10-29.
6. Bergmark K, Avall-Lundqvist E, Dickman PW, Henningsohn
L, Steineck G. Vaginal changes and sexuality in women with
a history of cervical cancer. N Engl J Med. 1999;340:1383-9.
7. Scotti RJ, Bergman A, Bhatia NN, Ostergard DR. Urodynamic
changes in urethrovesical function after radical hysterectomy.
Obstet Gynecol. 1986;68:111-20.
8. Sood AK, Nygaard I, Shahin MS, Sorosky JI, Lutgendorf SK,
Rao SS. Anorectal dysfunction after surgical treatment for cer-
vical cancer. J Am Coll Surg. 2002;195:513-9.
9. Nam JH, Park JY, Kim DY, Kim JH, Kim YM, Kim YT. Laparo-
scopic versus open radical hysterectomy in early-stage cervical
cancer: long-term survival outcomes in a matched cohort
study. Ann Oncol. 2012;23:903-11.
10. Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Laparo-
scopic versus open radical hysterectomy in patients with stage
IB2 and IIA2 cervical cancer. J Surg Oncol. 2013;108:63-9.
11. Abu-Rustum NR, Gemignani ML, Moore K, Sonoda Y, Venka-
traman E, Brown C, et al. Total laparoscopic radical hysterec-
tomy with pelvic lymphadenectomy using the argon-beam
coagulator: pilot data and comparison to laparotomy. Gynecol
Oncol. 2003;91:402-9.
12. Bogani G, Cromi A, Uccella S, Serati M, Casarin J, Pinelli C, et
al. Laparoscopic versus open abdominal management of cer-
vical cancer: long-term results from a propensity-matched
analysis. J Minim Invasive Gynecol. 2014;21:857-62.
13. Frumovitz M, dos Reis R, Sun CC, Milam MR, Bevers MW,
Brown J, et al. Comparison of total laparoscopic and abdomi-
nal radical hysterectomy for patients with early-stage cervical
cancer. Obstet Gynecol. 2007;110:96-102.
14. Magrina JF, Kho RM, Weaver AL, Montero RP, Magtibay PM.
Robotic radical hysterectomy: comparison with laparoscopy
and laparotomy. Gynecol Oncol. 2008;109:86-91.
15. Wang W, Chu HJ, Shang CL, Gong X, Liu TY, Zhao YH, et al.
Long-term oncological outcomes after laparoscopic versus 
abdominal radical hysterectomy in stage IA2 to IIA2 cervical
cancer: a matched cohort study. Int J Gynecol Cancer. 2016;26:
1264-73.
16. Soliman PT, Frumovitz M, Sun CC, Dos Reis R, Schmeler KM,
Nick AM, et al. Radical hysterectomy: a comparison of surgical
approaches after adoption of robotic surgery in gynecologic
oncology. Gynecol Oncol. 2011;123:333-6.
17. Wright JD, Herzog TJ, Neugut AI, Burke WM, Lu YS, Lewin
SN, et al. Comparative effectiveness of minimally invasive and
abdominal radical hysterectomy for cervical cancer. Gynecol
Oncol. 2012;127:11-7.
18. Laparoscopic approach to cervical cancer (LACC) [Internet].
Bethesda, MD: U.S. National Library of Medicine; 2018 [cited
References
VOLUME 51 NUMBER 2 APRIL 2019  795
Jin Hee Kim, Comparative Effectiveness of Laparoscopic Radical Hysterectomy 
2018 May 20]. Available from: https://clinicaltrials.gov/.
19. World Health Organization. International statistical classifica-
tion of diseases and related health problems, 10th rev. ed.
Geneva: World Health Organization; 1994.
20. Korean Health Insurance Review and Assessment Service.
Cost of health insurance medical care benefits. Seoul: Korean
Health Insurance Review and Assessment Service; 2016.
21. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity
measures for use with administrative data. Med Care. 1998;36:
8-27.
22. Sohn S, Kim J, Chung CK, Lee NR, Park E, Chang UK, et al. A
nationwide epidemiological study of newly diagnosed spine
metastasis in the adult Korean population. Spine J. 2016;16:
937-45.
23. Sohn S, Kim J, Chung CK, Lee NR, Sohn MJ, Kim SH. A 
nation-wide epidemiological study of newly diagnosed pri-
mary spine tumor in the adult Korean population, 2009-2011.
J Korean Neurosurg Soc. 2017;60:195-204.
24. Robins JM, Hernan MA, Brumback B. Marginal structural
models and causal inference in epidemiology. Epidemiology.
2000;11:550-60.
25. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ,
Vermeulen MJ. Analysis of observational studies in the pres-
ence of treatment selection bias: effects of invasive cardiac
management on AMI survival using propensity score and 
instrumental variable methods. JAMA. 2007;297:278-85.
26. Wright JD, Burke WM, Tergas AI, Hou JY, Huang Y, Hu JC, et
al. Comparative effectiveness of minimally invasive hysterec-
tomy for endometrial cancer. J Clin Oncol. 2016;34:1087-96.
27. Barnett JC, Judd JP, Wu JM, Scales CD Jr, Myers ER, Havrilesky
LJ. Cost comparison among robotic, laparoscopic, and open
hysterectomy for endometrial cancer. Obstet Gynecol. 2010;
116:685-93.
28. Rauh-Hain JA. Comparative effectiveness of minimally inva-
sive staging surgery in women with early stage cervical can-
cer. In: Proceedings of the Society of Gynecologic Oncologists;
2018 Mar 24-27; New Orleans, LA.
29. Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira MA,
Ribeiro R. Phase III randomized trial of laparoscopic or robotic
versus abdominal radical hysterectomy in patients with early-
stage cervical cancer: LACC Trial. In: Proceedings of the 49th
Annual Meeting of the Society of Gynecologic Oncologists;
2018 Mar 24-27; New Orleans, LA. Chicago, IL: Society of 
Gynecologic Oncology; 2018.
30. Park JY, Nam JH. How should gynecologic oncologists react
to the unexpected results of LACC trial? J Gynecol Oncol.
2018;29:e74.
31. Kimmig R, Ind T. Minimally invasive surgery for cervical can-
cer: consequences for treatment after LACC Study. J Gynecol
Oncol. 2018;29:e75.
32. Kanao H, Aoki Y, Takeshima N. Unexpected result of mini-
mally invasive surgery for cervical cancer. J Gynecol Oncol.
2018;29:e73.
796 CANCER  RESEARCH  AND  TREATMENT
Cancer Res Treat. 2019;51(2):788-796
